Meta tags:
description=Explore pharmaceuticals news, analysis, projects and industry insights from Pharmaceutical Technology. Stay informed on developments shaping the sector.;

Headings (most frequently used words):

the, for, in, sections, pharma, and, to, latest, pharmaceutical, of, sign, up, leading, industry, our, ai, 2026, data, insights, with, digital, companies, intelligence, globaldata, themes, us, investment, but, deals, next, generation, on, deal, clinical, approval, therapeutics, daily, news, round, more, gene, therapy, artificial, q3, providers, solutions, technology, report, from, partners, analysis, accelerate, decision, making, led, confidence, buyer, guides, reports, magazine, thank, you, subscribing, targets, chinese, biotech, licensing, remain, exempt, building, sustainable, centres, gilead, spends, 28bn, pepstar, potential, icotyde, rival, celltrion, kaigene, 580m, licence, kg013, roche, sales, grow, pipeline, trimmed, down, podcast, impact, prediction, markets, sector, astrazeneca, bags, another, indication, ultomiris, igan, astellas, proteins, miniprotein, egypt, reforms, obsolete, pricing, framework, cphi, manufacturers, put, work, danish, fast, track, model, inspires, growth, national, reimbursement, rates, global, systems, unprepared, rising, threat, invasive, fungal, infections, give, your, business, an, edge, drug, delivery, bottleneck, isn, innovation, it, industrial, capacity, australia, starts, investigation, into, openai, medicare, breach, how, dfe, supports, confident, continuous, manufacturing, decisions, partnership, will, determine, success, transition, low, gwp, pmdis, bristol, myers, nvidia, join, forces, build, life, science, most, powerful, factory, cell, recombinant, aav, revealed, trials, theme, private, equity, canada, remained, flat, 2024, bnt, 325, by, biontech, malignant, mesothelioma, likelihood, health, dtx, services, strategic, key, lead, focus, bio, outsourcing, september, idweek, pre, conference, coverage, gonorrhea, market, view, current, future, competitive, landscape, ulcerative, colitis, uc, epidemiology, forecast, 2035, venture, capital, trends, newsletter, brief, would, also, like, subscribe,

Text of the page (most frequently used words):
and (42), the (34), for (24), our (18), data (16), insights (16), islands (15), news (14), #pharmaceutical (13), #pharma (13), industry (12), your (12), more (10), 2026 (9), leading (9), services (9), with (8), view (8), technology (8), latest (8), events (8), new (7), you (7), globaldata (7), content (7), corporate (7), buyer (7), guides (7), intelligence (7), approval (7), clinical (7), innovation (7), sections (7), solutions (6), republic (6), sign (6), artificial (6), likelihood (6), deals (6), therapy (6), webinars (6), company (6), analysis (5), marketing (5), from (5), how (5), saint (5), equity (5), health (5), digital (5), companies (5), covid (5), partner (5), social (5), drug (5), but (5), next (5), comment (5), premium (5), features (5), newsletters (4), about (4), media (4), all (4), information (4), personal (4), can (4), email (4), address (4), subscribe (4), focus (4), south (4), guinea (4), island (4), central (4), private (4), investment (4), business (4), magazine (4), reports (4), disease (4), themes (4), global (4), webinar (4), footer (3), login (3), password (3), privacy (3), policy (3), close (3), visit (3), including (3), future (3), are (3), that (3), arab (3), french (3), france (3), canada (3), devices (3), management (3), give (3), edge (3), issue (3), market (3), landscape (3), unspecified (3), nervous (3), system (3), 2024 (3), trials (3), responsibility (3), robotics (3), internet (3), things (3), environmental (3), sustainability (3), cybersecurity (3), governance (3), cloud (3), demand (3), glp (3), delivery (3), analyst (3), manufacturers (3), pricing (3), remain (3), buy (3), cfooterexist (2), document (2), before (2), lost (2), newsletter (2), delivered (2), contact (2), advertise (2), site (2), may (2), use (2), process (2), share (2), rights (2), respect (2), unsubscribe (2), communications (2), intended (2), subscribers (2), warrant (2), submitted (2), virgin (2), british (2), georgia (2), samoa (2), territory (2), korea (2), jersey (2), italy (2), egypt (2), congo (2), china (2), australia (2), venture (2), capital (2), pharmaceuticals (2), banking (2), healthcare (2), daily (2), round (2), free (2), read (2), report (2), key (2), generation (2), providers (2), therapeutics (2), cell (2), disorders (2), life (2), coronavirus (2), 2019 (2), national (2), remained (2), flat (2), accelerate (2), decisions (2), decision (2), led (2), confidence (2), activity (2), treatment (2), gene (2), science (2), will (2), supports (2), manufacturing (2), bottleneck (2), isn (2), industrial (2), capacity (2), model (2), cphi (2), deal (2), podcast (2), annabel (2), kartal (2), allen (2), potential (2), building (2), biotech (2), first (2), development (2), molecule (2), videos (2), white (2), papers (2), releases (2), products (2), categories (2), patents (2), filings (2), jobs (2), orano (2), med (2), alpha (2), laboratory (2), atlab (2), onnaing (2), find (2), embocaps (2), supplyside (2), women (2), shifting (2), systemic (2), hurdles (2), access (2), area (2), projects (2), opinion (2), menu (2), skip (2), var, getelementsbyclassname, length, queryselector, prefooter, registration, disabled, get, register, back, receive, plc, powered, sitemap, terms, conditions, editorial, approach, license, procurement, across, network, thank, subscribing, monthly, would, also, like, kosovo, zimbabwe, zambia, yemen, western, sahara, wallis, futuna, vietnam, venezuela, vanuatu, uzbekistan, uruguay, minor, outlying, united, emirates, ukraine, uganda, tuvalu, turks, caicos, turkmenistan, turkey, tunisia, trinidad, tobago, tonga, tokelau, togo, timor, leste, thailand, tanzania, tajikistan, taiwan, syrian, switzerland, sweden, swaziland, svalbard, jan, mayen, suriname, sudan, sri, lanka, spain, sandwich, africa, somalia, solomon, slovenia, slovakia, singapore, sierra, leone, seychelles, serbia, senegal, saudi, arabia, sao, tome, principe, san, marino, vincent, grenadines, pierre, miquelon, lucia, kitts, nevis, helena, ascension, tristan, cunha, rwanda, russian, federation, romania, réunion, qatar, puerto, rico, portugal, poland, pitcairn, philippines, peru, paraguay, papua, panama, palestinian, palau, pakistan, oman, norway, northern, mariana, norfolk, niue, nigeria, niger, nicaragua, zealand, caledonia, netherlands, nepal, nauru, namibia, myanmar, mozambique, morocco, montserrat, montenegro, mongolia, monaco, moldova, micronesia, mexico, mayotte, mauritius, mauritania, martinique, marshall, malta, mali, maldives, malaysia, malawi, madagascar, macedonia, former, yugoslav, macao, luxembourg, lithuania, liechtenstein, libyan, jamahiriya, liberia, lesotho, lebanon, latvia, lao, kyrgyzstan, kuwait, north, kiribati, kenya, kazakhstan, jordan, japan, jamaica, israel, isle, man, ireland, iraq, iran, indonesia, india, iceland, hungary, hong, kong, honduras, holy, see, heard, mcdonald, haiti, guyana, bissau, guernsey, guatemala, guam, guadeloupe, grenada, greenland, greece, gibraltar, ghana, germany, gambia, gabon, southern, territories, polynesia, guiana, finland, fiji, faroe, falkland, ethiopia, estonia, eritrea, equatorial, salvador, ecuador, dominican, dominica, djibouti, denmark, czech, cyprus, curaçao, cuba, croatia, côte, ivoire, costa, rica, cook, democratic, comoros, colombia, cocos, christmas, chile, chad, african, cayman, cape, verde, cameroon, cambodia, burundi, burkina, faso, bulgaria, brunei, darussalam, indian, ocean, brazil, bouvet, botswana, bosnia, herzegovina, bonaire, sint, eustatius, saba, bolivia, bhutan, bermuda, benin, belize, belgium, belarus, barbados, bangladesh, bahrain, bahamas, azerbaijan, austria, aruba, armenia, argentina, antigua, barbuda, antarctica, anguilla, angola, andorra, american, algeria, albania, åland, afghanistan, usa, country, travel, tourism, hospitality, transportation, logistics, telecom, sport, retail, real, estate, power, utilities, packaging, oil, gas, mining, medical, publishing, advertising, consulting, legal, insurance, staffing, recruitment, hospitals, fitness, government, trade, bodies, ngos, foodservice, consumer, construction, chemicals, payments, automotive, asset, agriculture, aerospace, defense, security, academia, education, brief, online, click, cover, have, each, inbox, 795, trends, 9995, ulcerative, colitis, epidemiology, forecast, 2035, 3495, gonorrhea, current, competitive, 1500, idweek, pre, conference, coverage, 2950, bio, outsourcing, september, lead, strategic, dtx, cd19, cd22, car, cells, shanghai, biomed, union, biotechnology, lymphomas, nmda, regulator, boehringer, ingelheim, international, paclitaxel, innoup, farma, solid, tumor, fosigotifator, calico, sciences, vaccine, biotec, group, pneumonia, bnt, 325, biontech, malignant, mesothelioma, theme, discover, combine, proprietary, human, expertise, purpose, built, uncover, better, making, continues, hotbed, patent, driven, evolution, paradigms, recombinant, aav, revealed, bristol, myers, nvidia, join, forces, build, most, powerful, factory, partnership, determine, success, transition, low, gwp, pmdis, dfe, confident, continuous, starts, investigation, into, openai, medicare, breach, surging, injectable, therapies, exposing, constraint, not, ability, industrialise, manufacture, scale, systems, unprepared, rising, threat, invasive, fungal, infections, jon, aderanti, danish, fast, track, inspires, growth, reimbursement, rates, catherine, longworth, put, work, leyla, hasanzadeh, reforms, obsolete, framework, astellas, proteins, miniprotein, astrazeneca, bags, another, indication, ultomiris, igan, impact, prediction, markets, sector, roche, sales, grow, pipeline, trimmed, down, celltrion, kaigene, 580m, licence, kg013, gilead, spends, 28bn, pepstar, icotyde, rival, jam, bensilum, sustainable, centres, robert, barrie, numerous, types, popular, newco, impacted, proposed, rule, targets, chinese, licensing, exempt, dose, phase, strategy, focused, advancing, guidewire, performance, alleima, materials, design, applications, summit, cdmo, attend, milan, smarter, selection, help, risk, small, update, related, immedica, marinus, 151m, hovione, facility, expansion, foreign, direct, 1ra, non, responders, tackling, hidden, challenge, behind, obesity, epidemic, takeaways, easd, where, headed, maximising, putting, quality, supply, chain, chapter, trial, precision, medicine, diagnosis, care, accelerating, biopharmaceutical, control, biopharma, playbooks, speed, partners, rankings, excellence, awards, respiratory, oncology, infectious, immunology, cardiovascular, home, search, page,

Text of the page (random words):
pharmaceutical technology news analysis industry insights skip to site menu skip to page content pt login menu search sections home news analysis features comment opinion projects data insights pharma clinical trials drug manufacturers therapy area cardiovascular central nervous system immunology infectious disease oncology respiratory pricing and market access themes artificial intelligence corporate governance cloud cybersecurity environmental sustainability internet of things robotics social responsibility covid 19 insights deals jobs filings patents social media companies company a z company categories products services company releases white papers videos buyer s guides partner content webinar events webinar events all webinars events events webinars on demand webinars buy reports excellence awards innovation rankings magazine newsletters globaldata about us advertise with us contact us our marketing solutions globaldata reports visit globaldata from our partners biopharma playbooks solutions at the speed of science control and confidence in clinical data management accelerating biopharmaceutical innovation precision medicine and digital health innovation for disease diagnosis care and treatment the next chapter of clinical trial services putting quality first in the pharma supply chain maximising molecule potential news analysis sections features comment opinion projects a z data insights latest women s health landscape shifting but systemic hurdles remain podcast key takeaways from easd 2026 on where glp 1s are headed glp 1ra non responders tackling a hidden challenge behind the obesity epidemic pharma sections clinical trials drug manufacturers therapy area pricing and market access latest find embocaps at supplyside global 2026 orano med s alpha therapy laboratory atlab onnaing france women s health landscape shifting but systemic hurdles remain themes sections artificial intelligence cloud corporate governance cybersecurity environmental sustainability internet of things robotics social responsibility covid 19 foreign direct investment latest find embocaps at supplyside global 2026 orano med s alpha therapy laboratory atlab onnaing france hovione s pharmaceutical manufacturing facility expansion new jersey us insights sections deals jobs filings patents social media latest immedica to buy marinus pharmaceuticals for 151m private equity deals in pharmaceutical in canada remained flat in q3 2024 q3 2024 update artificial intelligence related private equity activity in the pharmaceutical industry companies sections company a z company categories products services company releases white papers videos buyer s guides partner content latest can smarter technology selection help de risk small molecule development drug delivery s next bottleneck isn t innovation it s industrial capacity leading cdmo to attend cphi milan 2026 in italy webinar events sections webinar events all webinars events events webinars on demand webinars latest global pharma and biotech summit advancing guidewire performance with alleima materials design and clinical applications before the first dose building a phase i strategy that supports the next development decision focused buy reports newsletters pt news us targets chinese biotech investment but licensing deals remain exempt numerous types of equity deals including the popular newco model will be impacted by the proposed rule robert barrie premium features building the next generation of sustainable data centres in pharma jam bensilum and annabel kartal allen news gilead spends 1 28bn on pepstar s potential icotyde rival annabel kartal allen news celltrion and kaigene sign 580m licence deal for kg013 news roche s pharma sales grow 7 but pipeline trimmed down features podcast the impact of prediction markets on the clinical sector news astrazeneca bags another us indication for ultomiris with igan approval news astellas and ai proteins sign miniprotein therapeutics deal analysis view more premium analyst comment egypt reforms obsolete pharmaceutical pricing framework leyla hasanzadeh premium features cphi 2026 pharma manufacturers put ai to work catherine longworth premium analyst comment danish fast track model inspires growth in national reimbursement rates jon aderanti premium analyst comment global systems unprepared for rising threat of invasive fungal infections globaldata healthcare sign up for our daily news round up give your business an edge with our leading industry insights sign up themes view more partner content drug delivery s next bottleneck isn t innovation it s industrial capacity surging demand for injectable therapies led by glp 1s is exposing a new constraint in drug delivery not innovation but the ability to industrialise and manufacture devices at scale more themes artificial intelligence cloud corporate governance cybersecurity environmental sustainability internet of things robotics social responsibility covid 19 news australia starts investigation into openai medicare breach partner content how dfe pharma supports confident continuous manufacturing decisions partner content industry partnership will determine the success of the transition to low gwp pmdis news bristol myers nvidia join forces to build life science s most powerful ai factory data insights view more data insights cell gene therapy the leading companies in recombinant aav gene therapy revealed the pharmaceutical industry continues to be a hotbed of patent innovation activity is driven by the evolution of treatment paradigms accelerate decision making with data led confidence combine proprietary data human expertise and purpose built ai to uncover insights and accelerate better business decisions discover our solutions data insights leading clinical trials companies in the artificial intelligence theme data insights private equity deals in pharmaceutical in canada remained flat in q3 2024 data insights bnt 325 by biontech for malignant mesothelioma likelihood of approval more insights coronavirus disease 2019 covid 19 vaccine by china national biotec group for coronavirus disease 2019 covid 19 pneumonia likelihood of approval fosigotifator by calico life sciences for unspecified central nervous system disorders likelihood of approval paclitaxel by innoup farma for solid tumor likelihood of approval nmda regulator by boehringer ingelheim international for unspecified central nervous system disorders likelihood of approval cd19 cd22 car t cells by shanghai biomed union biotechnology for unspecified b cell lymphomas likelihood of approval buyer s guides view more buyer s guides digital health and digital therapeutics dtx services and providers for the pharmaceutical industry buyer s guides leading artificial intelligence ai companies in pharma buyer s guides leading strategic intelligence solutions for the pharmaceutical industry buyer s guides key lead generation providers and technology solutions for the pharmaceutical industry globaldata reports view more bio pharmaceutical outsourcing report september 2026 2950 00 idweek 2026 pre conference coverage 1500 00 gonorrhea market view current and future competitive landscape 3495 00 ulcerative colitis uc epidemiology report and forecast to 2035 9995 00 venture capital investment trends in pharma q3 2026 795 00 digital magazine view more latest issue pharma technology focus pharma technology focus is our digital magazine free to read online on all devices click the magazine cover to read the latest issue you can subscribe for free to have each new issue delivered to your inbox subscribe sign up for our daily news round up give your business an edge with our leading industry insights give your business an edge with our leading industry insights close close sign up to the newsletter in brief industry academia education aerospace defense security agriculture asset management automotive banking payments chemicals construction consumer foodservice government trade bodies and ngos health fitness hospitals healthcare hr staffing recruitment insurance investment banking legal services management consulting marketing advertising media publishing medical devices mining oil gas packaging pharmaceuticals power utilities private equity real estate retail sport technology telecom transportation logistics travel tourism hospitality venture capital country uk usa afghanistan åland islands albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bonaire sint eustatius and saba bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei darussalam bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos islands colombia comoros congo democratic republic of the congo cook islands costa rica côte d ivoire croatia cuba curaçao cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands faroe islands fiji finland france french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guinea bissau guyana haiti heard island and mcdonald islands holy see honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan lao latvia lebanon lesotho liberia libyan arab jamahiriya liechtenstein lithuania luxembourg macao macedonia the former yugoslav republic of madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands new caledonia new zealand nicaragua niger nigeria niue norfolk island northern mariana islands norway oman pakistan palau palestinian territory panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar réunion romania russian federation rwanda saint helena ascension and tristan da cunha saint kitts and nevis saint lucia saint pierre and miquelon saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa south georgia and the south sandwich islands spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syrian arab republic taiwan tajikistan tanzania thailand timor leste togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates us minor outlying islands uruguay uzbekistan vanuatu venezuela vietnam british virgin islands us virgin islands wallis and futuna western sahara yemen zambia zimbabwe kosovo i would also like to subscribe to pharma technology focus pharmaceutical technology focus monthly visit our privacy policy for more information about our services how we may use process and share your personal data including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address subscribe visit our privacy policy for more information about our services how we may use process and share your personal data including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address thank you for subscribing view all newsletters from across the globaldata media network close the leading site for news and procurement in the pharmaceutical industry about us advertise with us license our content contact us editorial approach newsletters our marketing solutions privacy policy terms and conditions sitemap powered by globaldata plc 2026 receive our newsletter data insights and analysis delivered to you var cfooterexist document getelementsbyclassname c footer if cfooterexist length 0 document queryselector footer c footer before prefooter lost password back login register get new password lost password login registration is disabled